Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,699 | 376 | 99.1% |
| Education | $92.14 | 14 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,184 | 69 | $0 (2024) |
| ABBVIE INC. | $1,294 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $814.73 | 22 | $0 (2024) |
| Amarin Pharma Inc. | $766.24 | 18 | $0 (2023) |
| PFIZER INC. | $756.31 | 94 | $0 (2024) |
| Lilly USA, LLC | $617.34 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $462.81 | 19 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $408.86 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $408.48 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $292.41 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,256 | 169 | ABBVIE INC. ($615.48) |
| 2023 | $1,945 | 100 | AbbVie Inc. ($678.95) |
| 2022 | $733.33 | 11 | Novo Nordisk Inc ($564.20) |
| 2021 | $383.76 | 5 | Novo Nordisk Inc ($241.49) |
| 2020 | $344.80 | 4 | Novo Nordisk Inc ($261.65) |
| 2019 | $491.76 | 7 | Amarin Pharma Inc. ($220.97) |
| 2018 | $618.41 | 13 | Kowa Pharmaceuticals America, Inc. ($210.54) |
| 2017 | $2,019 | 81 | Boehringer Ingelheim Pharmaceuticals, Inc. ($374.21) |
All Payment Transactions
390 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Obesity | ||||||
| 12/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: VACCINES | ||||||
| 11/27/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Oncology | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Endocrinology | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: VACCINES | ||||||
| 10/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 192 | 231 | $26,723 | $12,513 |
| 2022 | 9 | 836 | 1,412 | $207,675 | $72,257 |
| 2021 | 11 | 1,178 | 1,959 | $310,361 | $111,934 |
| 2020 | 14 | 1,414 | 2,221 | $322,772 | $111,577 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 79 | $9,176 | $4,224 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 50 | $9,924 | $2,946 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $3,670 | $2,019 | 55.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $1,360 | $1,151 | 84.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 11 | 11 | $1,045 | $891.00 | 85.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 14 | $700.00 | $556.55 | 79.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $648.00 | $530.10 | 81.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 25 | $200.00 | $196.00 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 221 | 542 | $130,012 | $41,010 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 111 | 207 | $35,460 | $12,254 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 111 | 111 | $29,415 | $11,053 | 37.6% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 55 | 56 | $4,515 | $3,828 | 84.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 56 | $2,464 | $1,586 | 64.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 83 | 83 | $2,988 | $1,471 | 49.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 178 | 334 | $2,672 | $989.82 | 37.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 11 | $77.00 | $37.69 | 48.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 12 | $72.00 | $26.49 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 346 | 835 | $197,060 | $65,605 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 182 | 182 | $48,230 | $18,939 | 39.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 212 | $35,828 | $12,824 | 35.8% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 81 | 81 | $5,901 | $5,278 | 89.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 21 | 23 | $8,579 | $3,751 | 43.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 73 | 73 | $2,628 | $1,338 | 50.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 81 | 81 | $3,564 | $1,328 | 37.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $4,512 | $1,323 | 29.3% |
About Dr. David Chalker, D.O
Dr. David Chalker, D.O is a Family Medicine healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497726293.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Chalker, D.O has received a total of $9,792 in payments from pharmaceutical and medical device companies, with $3,256 received in 2024. These payments were reported across 390 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($9,699).
As a Medicare-enrolled provider, Chalker has provided services to 3,620 Medicare beneficiaries, totaling 5,823 services with total Medicare billing of $308,281. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location York, PA
- Active Since 01/30/2006
- Last Updated 07/20/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497726293
Products in Payments
- Vascepa (Drug) $766.24
- VRAYLAR (Drug) $715.99
- Ozempic (Drug) $607.80
- Rybelsus (Drug) $592.81
- ELIQUIS (Drug) $527.20
- VOQUEZNA (Drug) $408.86
- RYBELSUS (Drug) $382.58
- MOUNJARO (Drug) $344.25
- QULIPTA (Drug) $333.29
- JARDIANCE (Drug) $295.25
- BREZTRI (Drug) $292.65
- AIRSUPRA (Drug) $275.53
- TRELEGY ELLIPTA (Drug) $271.16
- NURTEC ODT (Drug) $245.06
- BELSOMRA (Drug) $217.32
- Livalo (Drug) $210.54
- Wegovy (Drug) $188.53
- FARXIGA (Drug) $181.68
- PREVNAR 20 (Biological) $174.56
- UBRELVY (Drug) $151.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in York
Dr. Eric Barr, D.o, D.O
Family Medicine — Payments: $31,045
Dr. Thomas Hargest, Md, Phd, MD, PHD
Family Medicine — Payments: $18,717
John Manubay, Md, MD
Family Medicine — Payments: $14,930
Michael Leser, D.o, D.O
Family Medicine — Payments: $12,485
Dr. Thomas Trojian, Md, MD
Family Medicine — Payments: $8,722
Dr. Wanda Filer, Md, MD
Family Medicine — Payments: $8,695